{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:51Z","timestamp":1792784991474,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Agency of Sichuan Province","award":["2019YFS0287"],"award-info":[{"award-number":["2019YFS0287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to investigate the influence of\n                    <jats:italic>TPMT*3C, ITPA, NUDT15<\/jats:italic>\n                    , and 6-thioguanine nucleotides (6-TGN) on azathioprine (AZA)-induced myelosuppression in Southwest China patients with autoimmune hepatitis (AIH). A total of 113 Chinese patients with AIH receiving AZA maintenance treatment were evaluated. The relevant clinical data of the patients were collected from the hospital information system. Genotyping of\n                    <jats:italic>TPMT*3C(rs1142345), ITPA (rs1127354) and NUDT15(rs116855232)<\/jats:italic>\n                    was conducted using a TaqMan double fluorescent probe. The concentration of 6-TGN was determined using UPLC-MS\/MS. Among AIH patients treated with AZA, 40 (35.4%) exhibited different degrees of myelosuppression. The\n                    <jats:italic>NUDT15<\/jats:italic>\n                    variant was associated with leukopenia (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20098.26\u00a0\u00d7\u00a010\n                    <jats:sup>\u20137<\/jats:sup>\n                    ; OR\u2009=\u20097.5; 95% CI 3.08\u201318.3) and neutropenia (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20093.54\u00a0\u00d7\u00a010\n                    <jats:sup>\u20136<\/jats:sup>\n                    ; OR\u2009=\u20098.05; 95% CI 2.96\u201321.9); however, no significant association with myelosuppression was observed for\n                    <jats:italic>TPMT*3C<\/jats:italic>\n                    and\n                    <jats:italic>ITPA<\/jats:italic>\n                    variants (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&gt;\u20090.05). There was no significant difference in 6-TGN concentration between AIH patients with or without myelosuppression (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.556), nor was there a significant difference between patients with variant alleles of\n                    <jats:italic>TPMT*3C, ITPA,<\/jats:italic>\n                    or\n                    <jats:italic>NUDT15<\/jats:italic>\n                    and wild-type patients (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&gt;\u20090.05). Interestingly, it was found that patients with a lower BMI had higher adjusted 6-TGN levels and a higher incidence of myelosuppression (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.026 and 0.003). This study confirmed that\n                    <jats:italic>NUDT15<\/jats:italic>\n                    variants are a potential independent risk predictor for AZA-induced leukopenia and neutropenia. BMI may be a crucial non-genetic factor that affects the concentration of AZA metabolites and myelosuppression. In addition, the 6-TGN concentration in red blood cells does not reflect the toxicity of AZA treatment, and new biomarkers for AZA therapeutic drug monitoring need further research.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-87095-0","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T06:09:07Z","timestamp":1618207747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Qiang","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuangao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"87095_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 63, 971\u20131004 (2015).","journal-title":"J Hepatol."},{"key":"87095_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jama.2019.0709","volume":"321","author":"GJ Walker","year":"2019","unstructured":"Walker, G. J. et al. Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease. JAMA 321, 773\u2013785 (2019).","journal-title":"JAMA"},{"key":"87095_CR3","doi-asserted-by":"publisher","first-page":"e1513","DOI":"10.1097\/MD.0000000000001513","volume":"94","author":"Y Qiu","year":"2015","unstructured":"Qiu, Y. et al. Safety profile of thiopurines in crohn disease: Analysis of 893 patient-years follow-up in a Southern China Cohort. Medicine 94, e1513 (2015).","journal-title":"Medicine"},{"key":"87095_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2217\/bmm.14.97","volume":"9","author":"SC Fong","year":"2015","unstructured":"Fong, S. C., Blaker, P. A., Arenas-Hernandez, M., Marinaki, A. M. & Sanderson, J. D. Getting the best out of thiopurine therapy: Thiopurine S-methyltransferase and beyond. Biomark Med. 9, 51\u201365 (2015).","journal-title":"Biomark Med."},{"key":"87095_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3389\/fphar.2018.01107","volume":"9","author":"SZ Lim","year":"2018","unstructured":"Lim, S. Z. & Chua, E. W. Revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring. Front. Pharmacol. 9, 1107 (2018).","journal-title":"Front. Pharmacol."},{"key":"87095_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","volume":"71","author":"TA de Beaumais","year":"2011","unstructured":"de Beaumais, T. A. et al. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br. J. Clin. Pharmacol. 71, 575\u2013584 (2011).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"87095_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","volume":"35","author":"L Chouchana","year":"2012","unstructured":"Chouchana, L., Narjoz, C., Beaune, P., Loriot, M. A. & Roblin, X. Review article: The benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Aliment. Pharmacol. Ther. 35, 15\u201336 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"87095_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10038-004-0183-y","volume":"49","author":"S Marsh","year":"2004","unstructured":"Marsh, S., King, C. R., Ahluwalia, R. & McLeod, H. L. Distribution of ITPA P32T alleles in multiple world populations. J. Hum. Genet. 49, 579\u2013581 (2004).","journal-title":"J. Hum. Genet."},{"key":"87095_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/bcpt.12958","volume":"122","author":"A Citterio-Quentin","year":"2018","unstructured":"Citterio-Quentin, A., Moulsma, M., Gustin, M. P., Lachaux, A. & Boulieu, R. ITPA activity in children treated by azathioprine: Relationship to the occurrence of adverse drug reactions and inflammatory response. Basic Clin. Pharmacol. Toxicol. 122, 588\u2013595 (2018).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"87095_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jpeds.2019.09.024","volume":"216","author":"M Wahlund","year":"2020","unstructured":"Wahlund, M. et al. The role of TPMT, ITPA, and NUDT15 variants during mercaptopurine treatment of Swedish pediatric patients with acute lymphoblastic leukemia. J. Pediatr. 216, 150\u2013157 (2020).","journal-title":"J. Pediatr."},{"key":"87095_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ng.3060","volume":"46","author":"SK Yang","year":"2014","unstructured":"Yang, S. K. et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat. Genet. 46, 1017\u20131020 (2014).","journal-title":"Nat. Genet."},{"key":"87095_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00535-015-1142-4","volume":"51","author":"A Asada","year":"2016","unstructured":"Asada, A. et al. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease. J. Gastroenterol. 51, 22\u201329 (2016).","journal-title":"J. Gastroenterol."},{"key":"87095_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/tpj.2015.43","volume":"16","author":"Y Kakuta","year":"2016","unstructured":"Kakuta, Y. et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenom. J. 16, 280\u2013285 (2016).","journal-title":"Pharmacogenom. J."},{"key":"87095_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/apt.13796","volume":"44","author":"X Zhu","year":"2016","unstructured":"Zhu, X. et al. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn\u2019s disease. Aliment. Pharmacol. Ther. 44, 967\u2013975 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"87095_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/jgh.13494","volume":"32","author":"SA Shah","year":"2017","unstructured":"Shah, S. A., Paradkar, M., Desai, D. & Ashavaid, T. F. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J. Gastroenterol. Hepatol. 32, 620\u2013624 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"87095_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12885-018-4398-2","volume":"18","author":"H Zhou","year":"2018","unstructured":"Zhou, H. et al. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?. BMC Cancer 18, 516 (2018).","journal-title":"BMC Cancer"},{"key":"87095_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/tpj.2015.75","volume":"16","author":"DC Liang","year":"2016","unstructured":"Liang, D. C. et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenom. J. 16, 536\u2013539 (2016).","journal-title":"Pharmacogenom. J."},{"key":"87095_CR18","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00277-017-3112-9","volume":"96","author":"X Yang","year":"2017","unstructured":"Yang, X., Xu, H., Yang, J. & Yang, L. Rare gene variants in a patient with azathioprine-induced lethal myelosuppression. Ann. Hematol. 96, 2131\u20132133 (2017).","journal-title":"Ann. Hematol."},{"key":"87095_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fphar.2019.00346","volume":"10","author":"X Fan","year":"2019","unstructured":"Fan, X., Yin, D., Men, R., Xu, H. & Yang, L. NUDT15 polymorphism confer increased susceptibility to thiopurine-induced leukopenia in patients with autoimmune hepatitis and related cirrhosis. Front. Pharmacol. 10, 346 (2019).","journal-title":"Front. Pharmacol."},{"key":"87095_CR20","first-page":"254","volume":"03","author":"The World Health Organization","year":"1992","unstructured":"The World Health Organization. Grading criteria for acute and subacute toxicity of anticancer drugs (WHO standard). Cancer 03, 254 (1992) (in Chinese).","journal-title":"Cancer"},{"key":"87095_CR21","doi-asserted-by":"publisher","first-page":"121802","DOI":"10.1016\/j.jchromb.2019.121802","volume":"1136","author":"Q Miao","year":"2020","unstructured":"Miao, Q. et al. Highly sensitive and rapid determination of azathioprine metabolites in whole blood lysate by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 1136, 121802 (2020).","journal-title":"J. Chromatogr. B"},{"key":"87095_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/cpt.1304","volume":"105","author":"A Relling","year":"2019","unstructured":"Relling, A. et al. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin. Pharmacol. Ther. 105, 1095\u20131105 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"87095_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","volume":"25","author":"L Wang","year":"2006","unstructured":"Wang, L. & Weinshilboum, R. Thiopurine S-methyltransferase pharmacogenetics: Insights, challenges and future directions. Oncogene 25, 1629\u20131638 (2006).","journal-title":"Oncogene"},{"key":"87095_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00280-018-3732-3","volume":"83","author":"S Khera","year":"2019","unstructured":"Khera, S. et al. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia. Cancer Chemother. Pharmacol. 83, 341\u2013348 (2019).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"87095_CR25","first-page":"3665","volume":"125","author":"Q Zhu","year":"2012","unstructured":"Zhu, Q. & Cao, Q. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine. Chin. Med. J. 125, 3665\u20133670 (2012).","journal-title":"Chin. Med. J."},{"key":"87095_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5217\/ir.2015.13.3.193","volume":"13","author":"KM Lee","year":"2015","unstructured":"Lee, K. M. et al. Use of thiopurines in inflammatory bowel disease: A consensus statement by the Korean Association for the study of intestinal diseases (KASID). Intest. Res. 13, 193\u2013207 (2015).","journal-title":"Intest. Res."},{"key":"87095_CR27","first-page":"4552","volume":"7","author":"X Ma","year":"2014","unstructured":"Ma, X. et al. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity. Int. J. Clin. Exp. Pathol. 7, 4552\u20134556 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"87095_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00535-017-1416-0","volume":"53","author":"Y Kakuta","year":"2018","unstructured":"Kakuta, Y., Kinouchi, Y. & Shimosegawa, T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: Prospects for clinical application of NUDT15 genotyping. J. Gastroenterol. 53, 172\u2013180 (2018).","journal-title":"J. Gastroenterol."},{"key":"87095_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2217\/pgs-2017-0147","volume":"19","author":"N Sutiman","year":"2018","unstructured":"Sutiman, N. et al. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients. Pharmacogenomics 19, 31\u201343 (2018).","journal-title":"Pharmacogenomics"},{"key":"87095_CR30","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1200\/JCO.2014.59.4671","volume":"33","author":"JJ Yang","year":"2015","unstructured":"Yang, J. J. et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J. Clin. Oncol. 33, 1235\u20131242 (2015).","journal-title":"J. Clin. Oncol."},{"key":"87095_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2018.00460","volume":"9","author":"X Fei","year":"2018","unstructured":"Fei, X. et al. NUDT15 R139C variants increase the risk of azathioprine-induced leukopenia in Chinese autoimmune patients. Front. Pharmacol. 9, 460 (2018).","journal-title":"Front. Pharmacol."},{"key":"87095_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13555-020-00360-4","volume":"10","author":"PW Huang","year":"2020","unstructured":"Huang, P. W., Tseng, Y. H. & Tsai, T. F. Predictive value of NUDT15 variants on neutropenia among Han Chinese patients with dermatologic diseases: a single-center observational study. Dermatol. Ther. 10, 263\u2013271 (2020).","journal-title":"Dermatol. Ther."},{"key":"87095_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0868-8","author":"DS Wang","year":"2020","unstructured":"Wang, D. S. et al. Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-020-0868-8 (2020).","journal-title":"Pediatr. Res."},{"key":"87095_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00535-018-1486-7","volume":"53","author":"Y Kakuta","year":"2018","unstructured":"Kakuta, Y. et al. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: A multicenter study. J. Gastroenterol. 53, 1065\u20131078 (2018).","journal-title":"J. Gastroenterol."},{"key":"87095_CR35","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41436-019-0448-7","volume":"21","author":"E Schaeffeler","year":"2019","unstructured":"Schaeffeler, E. et al. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry. Genet. Med. 21, 2145\u20132150 (2019).","journal-title":"Genet. Med."},{"key":"87095_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2478\/prilozi-2019-0006","volume":"40","author":"K Pavlovska","year":"2019","unstructured":"Pavlovska, K. et al. Importance of 6-thioguanine nucleotide metabolite monitoring in inflammatory bowel disease patients treated with azathioprine. Pril 40, 73\u201379 (2019).","journal-title":"Pril"},{"key":"87095_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/fcp.12412","volume":"33","author":"C Tron","year":"2019","unstructured":"Tron, C. et al. Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters. Fundam. Clin. Pharmacol. 33, 113\u2013121 (2019).","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87095-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87095-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87095-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:35:37Z","timestamp":1670031337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87095-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87095"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87095-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-123603\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7984"}}